Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Szarek

Michael Szarek PhD

Research Professor, Division of Cardiology, University of Colorado School of Medicine; Faculty Member, CPC Clinical Research, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Michael Szarek, PhD is a research professor in the Division of Cardiology at the University of Colorado School of Medicine, as well as a faculty member of CPC Clinical Research, an Academic Research Organization affiliated with the University of Colorado Anschutz Medical Campus. Dr. Szarek was previously Professor and Chair of the Department of Epidemiology and Biostatistics in the School of Public Health at SUNY Downstate Health Sciences University.  Dr. Szarek earned a MS in biostatistics from Harvard School of Public Health and a PhD in biostatistics from New York University. While at Harvard, he was a Schering Plough Scholar and recipient of a National Cancer Institute (NCI) National Research Service Award training grant.  During his career, he has supported and served as a member of Executive Steering Committees and Data Safety Monitoring Committees for multiple landmark clinical trials, and has also held regulatory affairs leadership positions in industry, including filing five INDs for cancer therapeutics and leading interactions with worldwide regulatory agencies in multiple therapeutic areas. Dr. Szarek is currently a statistical editor for the Journal of the American College of Cardiology (JACC) and JACC – Cardiovascular Interventions.


Michael Szarek: reports serving as a consultant or research support (or both) from CiVi, Resverlogix, Lexicon, Baxter, Esperion, Amarin, NewAmsterdam, Silence, Sanofi, and Regeneron Pharmaceuticals, Inc.